返回
S
Sunita Ghosh
henry ford health
49H指数
746论文数
1.2W被引数
收录论文 211
发表时间
Docosahexaenoic acid (DHA) supplementation attenuates changes in the concentration, phenotype, and response of immune peripheral blood cells in breast cancer patients undergoing neoadjuvant therapy. Secondary findings from the DHA-WIN trial二十二碳六烯酸(DHA)补充剂可减轻接受新辅助治疗的乳腺癌患者外周血免疫细胞在浓度、表型及反应性方面的变化。DHA-WIN试验的次要发现
Exploratory outcomes of the DHA WIN randomized controlled trial: Supplementing women with docosahexaenoic acid did not reduce the impact of neoadjuvant breast cancer chemotherapy on quality of life or exercise behaviourDHA WIN随机对照试验的探索性结果:为女性补充docosahexaenoic acid并未减轻新辅助乳腺癌化疗对生活质量或运动行为的影响
PLOS ONE
IF2.6

